Subgroup Risk factor | Univariate analysis (OR, 95% CI) | Multivariate analysis (OR, 95% CI) |
---|---|---|
Relapse (N = 35) | ||
   Lack of sputum smear conversion to negative by 3 months | 4.58 (2.22-9.43) | 4.14 (1.92-9.01) |
   Missed doses during the intensive phase | 3.23 (0.96-10.9) | NS |
Treatment failure (N = 18) | ||
   Lack of sputum smear conversion to negative by 3 months | ** | ** |
   Comorbid conditions | 3.29 (1.08-9.99) | NS |
Treatment default (N = 27) | ||
   Male gender | 6.50 (1.51-28.1) | 4.56 (0.96-20.7) |
   Substance use†| 4.19 (1.83-9.56) | 2.73 (1.04-7.15) |
   Missed doses during the intensive phase | 12.9 (4.65-35.7) | 10.9 (3.47-34.0) |
   Hospitalization during treatment | 2.56 (1.04-6.23) | 3.84 (1.41-10.5) |